Revolution Medicines, Inc
Price
OptionsOpen the Sheet →FilingsNewest: 8-K, Material agreementSep 1 →InsidersNo open-market buys. 8 insiders sold $74.3M, 69 of 70 sales on a 10b5-1 plan.→HoldersBlackRock 6.4%Farallon 6.3%FMR 5.7%→Financing →PeersClosest companies: PRLD, ELVN, PMVP→
From the filings
Figures
- Revenue
- $0.00last 12 months
- Net income
- −$1.77Blast 12 months
- Operating cash flow
- −$1.06Blast 12 months
- Cash and equivalents
- $815.4Mat the last balance sheet
- Shares outstanding
- 214.2M shareson issue